Shares of San Francisco-based tech firm PagerDuty (NYSE: PD) opened at $36.75, up 53% from its IPO price of $24 on its first day of trading on NYSE. PagerDuty increased its IPO price range from $19 to $21 to a range of $21 to $23 on Tuesday. Market watchers expected the $1.8 billion valued company to open up between $30 and $32.
Yesterday, PagerDuty announced that its 9.07 million shares of common stock will be priced at $24 per share. Morgan Stanley and J.P. Morgan Securities acted as lead book-running managers for the offering. RBC Capital Markets and Allen & Company acted as joint bookrunners.
According to Crunchbase, the 10-year old software maker had raised over $170 million in six rounds of funding before going public. This includes investments from Andreessen Horowitz, Bessemer Venture Partners and Accel Partners.
Also read: Lyft and six other companies went public in March
For the fiscal year 2019 ended on January 31, 2019, net loss was $40.7 million compared to a net loss of $38.1 million in the previous year. Revenue grew 48% year-over-year to $117.8 million.
PagerDuty’s global customer base at the end of fiscal year 2019 grew to 11,212 from 9,793 at January 31, 2018. One-third of this customer base includes Fortune 500 companies. No single customer represented 5% or more of the company’s revenue for the fiscal year ended January 31, 2019.
PagerDuty’s SaaS-based solution provides insights to customers about their business performance, evaluates their applications and automate them, and increase their productivity.
Follow our Google News edition to get the latest stock market, earnings and financial news at your fingertips
Most Popular
CVX Earnings: Chevron reports lower revenue and profit for Q1 2024
Energy exploration company Chevron Corporation (NYSE: CVX) announced first-quarter 2024 financial results, reporting a decline in net profit and revenues. Net income attributable to Chevron Corporation was $5.50 billion or
ABBV Earnings: AbbVie reports lower adj. profit for Q1 2024; revenue edges up
Specialty biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) Friday announced first-quarter 2024 financial results, reporting a decline in adjusted earnings and a modest rise in revenues. The company reported worldwide net
CL Earnings: Key quarterly highlights from Colgate-Palmolive’s Q1 2024 financial results
Colgate-Palmolive Company (NYSE: CL) reported first quarter 2024 earnings results today. Net sales increased 6.2% year-over-year to $5.06 billion. Organic sales increased 9.8%. Net income attributable to Colgate-Palmolive Company was
Comments